RE: Immigration screening for latent tuberculosis infection

Medical Journal of Australia

Volumn 199, Issue 10, 2013, Pages 654-

  Denholm, Justin T ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID;

DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; HIGH RISK PATIENT; HUMAN; IMMIGRATION; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; LATENT TUBERCULOSIS; LETTER; OUTCOME ASSESSMENT; PREDICTION; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SCREENING TEST; SENSITIVITY ANALYSIS; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; MASS SCREENING; MIGRATION; NOTE; ORGANIZATION AND MANAGEMENT;

EMIGRATION AND IMMIGRATION; HUMANS; LATENT TUBERCULOSIS; MASS SCREENING;

EID: 84887792020     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja13.11007     Document Type: Letter

References (2)

1. McBryde E, Denholm JT. Risk of active tuberculosis in immigrants: effects of age, region of origin and time since arrival in a low-exposure setting. Med J Aust 2012; 197: 458-461.
2. Diel R, Loddenkemper R, Niemann S, et al. Negative and positive predictive value of a whole-blood interferon-γ release assay for developing active tuberculosis: an update. Am J Respir Crit Care Med 2011; 183: 88-95.